RNASET2 and ovarian carcinoma: Finally, an IHC survey on 88 human ovarian cancer specimens unveiled a negative correlation between FBXO6 and RNASET2 proteins expression, further pointing at a causal link between downregulation of RNASET2 protein in ovarian cancer and FBXO6 overexpression.